Condensed consolidated and combined statements of operations and comprehensive loss (USD $)	3 Months Ended		123 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Operating expenses
Research and development	$ 1,879,514	$ 572,967	$ 43,789,126
General and administrative	734,824	423,865	10,241,412
Total operating expenses	2,614,338	996,832	54,030,538
Other income (expenses)
Bank charges and financing costs	(453,808)	(1,834)	(590,023)
Interest income	2,835	1,446	365,881
Sale of equipment		29,396	134,553
Change in fair value of derivative liabilities (Note 8)	913,929		2,102,193
Amortization and extinguishment of remaining discount on preferred shares upon conversion of preferred shares	(1,884,233)	(25,438)	(2,395,575)
Foreign exchange loss	(192,063)	(17,005)	(239,484)
Total other income (expenses)	(1,613,340)	(13,435)	(622,455)
Net loss before income taxes	(4,227,678)	(1,010,267)	(54,652,993)
Income tax recovery			3,150,406
Net loss and comprehensive loss incurred in the development stage	(4,227,678)	(1,010,267)	(51,502,587)
Accretion for liquidation preference on preferred stock	(1,132,893)	(1,157,865)	(18,566,008)
Accretion for share issuance costs on preferred stock	(19,550)	(44,307)	(1,014,667)
Tax expense on preferred stock	(100,291)	(346,091)	(1,897,702)
Reversal of tax payable on preferred stock due to conversion of preferred stock	1,897,702		1,897,702
Extinguishment of remaining share issuance costs due to conversion of preferred stock	(439,227)		(439,227)
Total loss attributable to common stockholders	$ (4,021,937)	$ (2,558,530)	$ (71,522,489)
Basic and diluted loss per common stock (Note 7)	$ (1.28)	$ (8.48)	$ (179.45)
Basic and diluted weighted average common stock outstanding (Note 7)	3,148,481	301,745	398,573